Hy Hybrid

J1


Overview:

J1, aka Jack One, is a popular hybrid that feels like a sativa. The sativa-dominant strain will wake you up and get you back on track for the day, even if you are feeling fatigued. J1's two parent strains are Jack Herer and Skunk #1, a sativa and a hybrid. This combination results in an earthy-and-sweet strain with citrus undertones. It does not smell as strongly as some strains, but it most certainly has a noticeable aroma. Anyone that smokes the strain will notice that the smell wants to stick to your clothes, so if that bothers you, try your best to use a vaporizer instead. J1 is perfect for mental illnesses due to its psychoactive effects. It uplifts the user, brings them happiness, and leads to a strong feeling of euphoria. The user also will feel awake and energized. For creatives, this can be the perfect boost of creative energy that you need. Due to these strong psychoactive effects, this strain actively treats depression, stress, pain, fatigue, and even headaches. The sativa-like effects strong affect the head, which is how it can be helpful in combating head pressure. Just like all strains, J1 does have a few negatives. Dry mouth was very commonly reported, and dry eye was fairly common, as well. Less common but more severe side effects include dizziness and paranoia. The occasional user has noticed a worsening in headaches, so it is best that you use carefully if you struggle with marijuana-related head pressure.

Strain Attributes:

Effects

Creative

Energetic

Euphoric

Happy

Uplifted

Creative

Energetic

Euphoric

Happy

Uplifted

Medical Uses

Depression

Fatigue

Headaches

Pain

Stress

Depression

Fatigue

Headaches

Pain

Stress

Negatives

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid


Rate this Strain!

SPONSORS


FROM OUR BLOG


Interview

Medical Marijuana Cards - Who Qualifies for One and How Do You Actually Get One?

Qualifying conditions vary state by state. In more lax states, anxiety and insomnia are enough such as in California. In more strict states, severe and debilitating or life threatening conditions is required. Many states are now opening up to patients with problems like PTSD, and chronic pain-related syndromes.  Having said that, let us talk about all the other conditions. For example, epilepsy, inflammation, cancer, HIV, Alzheimers, Parkinsons, Crohn's disease, multiple sclerosis, ALS AIDS and others are generally qualifying across the nation.  
News

$113,000,000 and Counting in IRS 280E Tax Refunds - How the Cannabis Industry is about to Get a Cash Infusion!

In October, Cannabis.net covered the fact that the cannabis industry could be sitting on billions of dollars in tax refunds if the IRS 280E tax code is altered or eliminated for the marijuana industry. With towns and cities starting to refund excess taxes collected from cannabis companies in the name of "social impact fees", for things such as extra police work and trash pick up due to dispensaries entering their town, it appears the Federal government is also starting to give back taxes to the cannabis industry.
Videos

Is It Time to Buy Distressed Cannabis Assets and Companies, Yet?

Jimmy Young of Pro Cannabis Media sat down with legendary cannabis investor and Arcview CEO, Jeff Finkle to talk the current state of the cannabis market.  Jeffrey Finkle has been a venture and angel investor for 20 years.  He is CEO of the Arcview Asset Management Group and co-founder of the Arcview Members Fund. He also serves in Executive roles for Angel Round Capital, an active Angel seed Fund in NYC.  Jeff has been an advisor to tech and cannabis early stage companies for many years.  Named as one of the “25 Angel Investors in New York you Need to Know,”  Finkle publishes insights on his blog: www.finkabout.it.